Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07043712 · ClinicalTrials.gov registry record · NA

Effects of Pulse Consumption, Gut Microbiome, and Appetite in Healthy Participants

A NA study of Metabolic Syndrome and Microbial Colonization, sponsored by University of Missouri-Columbia.

Active
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT07043712 is a NA study of Metabolic Syndrome and Microbial Colonization that is active but no longer recruiting, run by University of Missouri-Columbia. The registered enrollment target is 44 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07043712, a NA study of Metabolic Syndrome and Microbial Colonization, is active but no longer recruiting, sponsored by University of Missouri-Columbia.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to investigate the effects of pulse consumption versus no pulse consumption on the gut microbiome, meal satiety, and short-chain fatty acid metabolomics.

Interventions

  • DIETARY_SUPPLEMENT High pulse consumption

Study Locations (1)

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2023-02-01
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT07043712

The ClinicalTrials.gov registry entry for NCT07043712 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which High pulse consumption is the first listed.

NCT07043712 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT07043712 about?

NCT07043712 is a clinical study titled "Effects of Pulse Consumption, Gut Microbiome, and Appetite in Healthy Participants". The purpose of the study is to investigate the effects of pulse consumption versus no pulse consumption on the gut microbiome, meal satiety, and short-chain fatty acid metabolomics.

What is the current status of trial NCT07043712?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2023-02-01. Estimated completion is 2026-12-31.

What conditions does trial NCT07043712 study?

This clinical trial studies the following conditions: Metabolic Syndrome, Microbial Colonization.

What interventions are being tested in trial NCT07043712?

The interventions under investigation include: High pulse consumption (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07043712?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07043712 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.